how to raise blood sugar on semaglutide July, 2026 Semaglutide Injection Protocol for Medical

In addition to mimicking the hormone responsible for satiety, Zepbound also imitates GIP (Glucose-Dependent Insulinotropic Polypeptide), which influences how the body breaks down sugar and fat, further reducing appetite

Details of ongoing phase 3 studies can be found on ClinicalTrials.gov

On average, patients on GLP-1 medication can lose 15% of their body weight in a year.* It is important to remember that results and timelines can vary

Average weight reduction reached 20.7 percent after 72 weeks at the 7.2 mg dose, compared to the 14.9 percent seen with 2.4 mg in STEP 1

Lifestyle modifications such as a reduced-calorie diet and increased physical activity are proven ways to achieve healthy weight loss